GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (FRA:CWY0) » Definitions » Equity-to-Asset

Clearmind Medicine (FRA:CWY0) Equity-to-Asset : 0.50 (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Clearmind Medicine's Total Stockholders Equity for the quarter that ended in Jan. 2024 was €4.63 Mil. Clearmind Medicine's Total Assets for the quarter that ended in Jan. 2024 was €9.27 Mil.

The historical rank and industry rank for Clearmind Medicine's Equity-to-Asset or its related term are showing as below:

FRA:CWY0' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.34   Med: 0.84   Max: 0.99
Current: 0.5

During the past 7 years, the highest Equity to Asset Ratio of Clearmind Medicine was 0.99. The lowest was -1.34. And the median was 0.84.

FRA:CWY0's Equity-to-Asset is ranked worse than
64.66% of 1559 companies
in the Biotechnology industry
Industry Median: 0.67 vs FRA:CWY0: 0.50

Clearmind Medicine Equity-to-Asset Historical Data

The historical data trend for Clearmind Medicine's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Equity-to-Asset Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Equity-to-Asset
Get a 7-Day Free Trial 0.75 0.98 0.93 -1.34 0.17

Clearmind Medicine Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 0.56 0.63 0.17 0.50

Competitive Comparison of Clearmind Medicine's Equity-to-Asset

For the Biotechnology subindustry, Clearmind Medicine's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearmind Medicine's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's Equity-to-Asset falls into.



Clearmind Medicine Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Clearmind Medicine's Equity to Asset Ratio for the fiscal year that ended in Oct. 2023 is calculated as

Equity to Asset (A: Oct. 2023 )=Total Stockholders Equity/Total Assets
=0.673/4.077
=

Clearmind Medicine's Equity to Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

Equity to Asset (Q: Jan. 2024 )=Total Stockholders Equity/Total Assets
=4.628/9.27
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clearmind Medicine  (FRA:CWY0) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Clearmind Medicine Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearmind Medicine (FRA:CWY0) Business Description

Traded in Other Exchanges
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Clearmind Medicine (FRA:CWY0) Headlines

No Headlines